Leading innovation in unprecedented times
WCG measurably improves the quality and efficiency of clinical trials, helping biopharmaceutical companies, CROs, and institutions facilitate the development of new treatments and therapies for patients.
How can we help you today?
I need to identify the optimal sites for my clinical trial.
I need to quickly increase enrollment for my study.
I need to reduce the cost and time of safety reporting.
We deliver unprecedented value to optimize your studies.
Regulatory-Grade Data
The WCG Knowledge Base™ is the industry’s largest database of site and investigator insights, benchmarks, and competitive performance data.
Broad Ecosystem of Institutional Relationships
We bring the power of our deep relationships with over 3,300 institutions, including nearly all of the largest Academic Medical Centers.
Expert Clinical & Operational Advisers
WCG services are powered by the combination of our deep clinical expertise and advanced technologies.
Highlighted Solutions
33%
acceleration in study start up
Study Fast-Start
Our insights-driven site selection and feasibility services together with our site budgeting and contracting services solve common trouble spots in the start up of clinical trials, helping Sponsors and CROs compress their study timelines by 33%.
85%
reduction in observation error rates
CNS
Our CNS suite of services apply the clinical expertise of WCG scientists and clinicians to mitigate the risks of bias, variability and human error, while addressing the root causes of failed and inconclusive CNS trials.
550+
clinical experts ready to engage to review critical data across your study
Oversight & Safety
We provide sponsors and CROs unmatched scientific competence and real-time access to assure every stage of your studies is achieving key clinical objectives – increasing your likelihood of success.
IN FOCUS: 2023 Clinical Research Trends & Insights
IN FOCUS: The Future of Clinical Research Sites
IN FOCUS: Collaboration and Inclusion of Patients in Clinical Trials
Featured Case Studies
SITE ACTIVATION
With WCG, Merck is able to identify sites for participation within 3 days, with feasibility response rates of over 80%.
SAFETY PORTAL